Skip to main content
. 2024 Apr 8;56(1):2337717. doi: 10.1080/07853890.2024.2337717

Table 3.

Distribution of depression and anxiety scores of the anabolic-androgenic steroid users and the control.

  AASa user group
Control group
p value
n % n %
Beck Anxiety Inventory scores
 Normal (<8) 18 72 25 100 0.010*
 Mild anxiety symptoms (8–15) 7 28 0 0
 Moderate anxiety symptoms (16–25) 0 0 0 0
 Severe anxiety symptoms (26–63) 0 0 0 0
Beck Depression Inventory scores
 Normal (<10) 18 72 25 100 0.012*
 Mild depressive symptoms (10–16) 4 16 0 0
 Moderate depressive symptoms (17–29) 3 12 0 0
 Severe depressive symptoms (30–63) 0 0 0 0

aAAS, anabolic-androgenic steroids.

* Fisher Exact Testing.